Barclays’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-19,628
| Closed | -$2.68M | – | 7657 |
|
|
2018
Q2 | $2.68M | Buy |
19,628
+14,709
| +299% | +$1.34M | ﹤0.01% | 2292 |
|
|
2018
Q1 | $387K | Buy |
4,919
+1,197
| +32% | +$88.3K | ﹤0.01% | 4222 |
|
|
2017
Q4 | $254K | Buy |
3,722
+2,057
| +124% | +$107K | ﹤0.01% | 4483 |
|
|
2017
Q3 | $66K | Buy |
1,665
+1,655
| +16,550% | +$63.9K | ﹤0.01% | 5196 |
|
|
2017
Q2 | $0 | Sell |
10
-421
| -98% | -$15.4K | ﹤0.01% | 7154 |
|
|
2017
Q1 | $14K | Sell |
431
-1,268
| -75% | -$31.6K | ﹤0.01% | 5967 |
|
|
2016
Q4 | $29K | Sell |
1,699
-859
| -34% | -$18.5K | ﹤0.01% | 5458 |
|
|
2016
Q3 | $60K | Sell |
2,558
-16,867
| -87% | -$383K | ﹤0.01% | 4874 |
|
|
2016
Q2 | $363K | Sell |
19,425
-18,078
| -48% | -$327K | ﹤0.01% | 3476 |
|
|
2016
Q1 | $675K | Buy |
37,503
+37,038
| +7,965% | +$597K | ﹤0.01% | 2872 |
|
|
2015
Q4 | $10K | Sell |
465
-8,699
| -95% | -$168K | ﹤0.01% | 5419 |
|
|
2015
Q3 | $165K | Sell |
9,164
-15,184
| -62% | -$379K | ﹤0.01% | 4284 |
|
|
2015
Q2 | $804K | Buy |
24,348
+22,934
| +1,622% | +$923K | ﹤0.01% | 3079 |
|
|
2015
Q1 | $69K | Buy |
1,414
+80
| +6% | +$3.63K | ﹤0.01% | 5080 |
|
|
2014
Q4 | $29K | Buy |
1,334
+853
| +177% | +$19.7K | ﹤0.01% | 6098 |
|
|
2014
Q3 | $9K | Buy |
481
+192
| +66% | +$4.58K | ﹤0.01% | 6964 |
|
|
2014
Q2 | $8K | Sell |
289
-44
| -13% | -$1.11K | ﹤0.01% | 6966 |
|
|
2014
Q1 | $11K | Sell |
333
-2,450
| -88% | -$79.6K | ﹤0.01% | 6900 |
|
|
2013
Q4 | $63K | Buy |
+2,783
| New | +$77.8K | ﹤0.01% | 6017 |
|
Barclays's FMI Position: Q3 2018 in Review
Barclays sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 19,628 shares — an estimated $2.68M sold.
Barclays first reported a position in FMI in Q4 2013 and held it in 19 quarters. The position peaked at $2.68M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Barclays reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Barclays sold 19,628 Foundation Medicine, Inc. shares in Q3 2018, an estimated $2.68M.
- Barclays first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 19 quarters.
- Barclays's Foundation Medicine, Inc. position peaked at $2.68M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.